TWiV 899: COVID-19 clinical update #114 with Dr. Daniel Griffin
In COVID-19 clinical update #114, Dr. Griffin discusses early treatment with ivermectin, procalcitonin not a reliable biomarker, vaccine in 6-11 year olds, FDA limits use of Janssen vaccine, does site of vaccine booster matter, sniffer dogs, monoclonals for hospitalized patients, risk assessment for public events, Paxlovid eligibility, and persistence of pediatric anosmia. Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode Effects of early treatment with Ivermectin (NEJM) Procalcitonin not a reliable biomarker (IDSA) Evaluation of vaccine in children 6 t...
Source: This Week in Virology - MP3 Edition - May 14, 2022 Category: Virology Authors: Vincent Racaniello Source Type: podcasts
Audio long-read: The quest to prevent MS — and understand other post-viral diseases
Results from a huge epidemiological study found that infection by the Epstein-Barr virus increases the risk of developing multiple sclerosis 32-fold. This result, combined with emerging mechanistic insights into how the virus triggers brain damage, are raising the prospect of treating or preventing MS.These advances come at a time when researchers are more interested than ever in what happens in the months and years following a viral infection, and highlights the issues untangling the relationships between infectious diseases and chronic conditions.This is an audio version of our Feature: The quest to prevent MS — and un...
Source: Nature Podcast - April 25, 2022 Category: Science Authors: Springer Nature Limited Source Type: podcasts
Inequity, society, and infectious diseases in the USA
Professor Samuel K. Roberts joins Gavin and Jessamy to discuss racial inequities in the USA and how infectious diseases historically find and exploit the gaps in societies. (Source: Listen to The Lancet)
Source: Listen to The Lancet - March 1, 2022 Category: General Medicine Authors: The Lancet Source Type: podcasts
COVID-19 Update: Omicron Variant
Infectious disease experts Adam Lauring, MD, PhD, and Carlos del Rio, MD, join JAMA Associate Editor Preeti Malani, MD, MSJ, for a discussion of the newly emerged Omicron variant, the potential for a 2021-2022 "twindemic" with flu, and the latest COVID-19 clinical updates. Recorded December 1, 2021. Related content: Omicron Has Reached the US—Here’s What Infectious Disease Experts Know About the Variant COVID-19 Update: Omicron Variant (Source: JAMA Author Interviews)
Source: JAMA Author Interviews - December 6, 2021 Category: General Medicine Authors: JAMA Network Source Type: podcasts
Ivermectin for preventing and treating COVID-19
Cochrane is producing a series of reviews relevant to the COVID-19 pandemic. In July 2021, we published the first version of our review on the effects of ivermectin for the prevention and treatment of COVID-19, in a collaboration between Cochrane's Infectious Diseases and Haematological Malignancy Groups. We asked one of the authors, Maria Popp from University Hospital Wuerzburg in Germany, to tell us about their findings. (Source: Podcasts from The Cochrane Library)
Source: Podcasts from The Cochrane Library - August 17, 2021 Category: General Medicine Authors: Cochrane Source Type: podcasts
TWiV 773: Laurie Garrett, pandemic prophet
Laurie Garrett, author of The Coming Plague, joins TWiV for a wide-ranging discussion of infectious disease and public health, including emerging infections, the role of wildlife markets in spillovers, and missteps in handling the COVID-19 pandemic. Hosts: Vincent Racaniello, Kathy Spindler, and Brianne Barker Guest: Laurie Garrett Subscribe (free): iTunes, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode Lauriegarrett.com The Coming Plague Betrayal of Trust Trump sabotaged coronavirus response (Foreign Policy) ASV Vaccine Town Hall Timestamps by Jolene. Thanks! Weekly Picks Brianne – A...
Source: This Week in Virology - MP3 Edition - June 27, 2021 Category: Virology Authors: Vincent Racaniello Source Type: podcasts
Stephen Thomas - Behind the scenes in the Pfizer vaccine trial
Never has the spotlight been as strong on a clinical trial as that on the Pfizer BioNTech vaccine, the first approved for covid-19.
In this interview, Joanne Silberner spoke to its lead principal investigator, Stephen Thomas chief of infectious diseases at SUNY Upstate Medical University, New York, became the lead principal investigator for one of the most closely watched clinical trials in history.
They discuss the moment th e positive results came through, what will happen to the people who are still enrolled in the trial, but got a placebo dose, and why the trial was designed in the way it was.www.bmj.com/coronavirus...
Source: The BMJ Podcast - March 8, 2021 Category: General Medicine Authors: BMJ talk medicine Source Type: podcasts
Stephen Thomas - Behind the scenes in the Pfizer vaccine trial
Never has the spotlight been as strong on a clinical trial as that on the Pfizer BioNTech vaccine, the first approved for covid-19.
In this interview, Joanne Silberner spoke to its lead principal investigator, Stephen Thomas chief of infectious diseases at SUNY Upstate Medical University, New York, became the lead principal investigator for one of the most closely watched clinical trials in history.
They discuss the moment the positive results came through, what will happen to the people who are still enrolled in the trial, but got a placebo dose, and why the trial was designed in the way it was.
www.bmj.com/coronaviru...
Source: The BMJ Podcast - March 8, 2021 Category: General Medicine Authors: BMJ Group Source Type: podcasts
The BMJ interview - Tom Frieden, former CDC director on why we thought we were prepared
It ’s been just over a year since the WHO declared the pandemic a “Public Health Emergency of International Concern” - if you cast your mind back to then, the news was full of reassurances about how prepared the UK and the USA were for a pandemic.
Now a year later, with the benefit of hindsight, that confidence was wildly overstated - but why was that, what is the gap between that theoretical readiness, and reality.
In this podcast we're joined by talking to Tom Frieden - former director of the Centres for Disease Control and Prevention, under President Obama, and who has a long history of public health leadership...
Source: The BMJ Podcast - February 2, 2021 Category: General Medicine Authors: BMJ talk medicine Source Type: podcasts
The BMJ interview - Tom Frieden, former CDC director on why we thought we were prepared
It’s been just over a year since the WHO declared the pandemic a “Public Health Emergency of International Concern” - if you cast your mind back to then, the news was full of reassurances about how prepared the UK and the USA were for a pandemic.
Now a year later, with the benefit of hindsight, that confidence was wildly overstated - but why was that, what is the gap between that theoretical readiness, and reality.
In this podcast we're joined by talking to Tom Frieden - former director of the Centres for Disease Control and Prevention, under President Obama, and who has a long history of public health leadership....
Source: The BMJ Podcast - February 2, 2021 Category: General Medicine Authors: BMJ Group Source Type: podcasts
The BMJ interview: Fixing America’s covid response in the Biden era
US president elect Joe Biden wasted no time in appointing a special advisory board of experts to guide America out of its coronavirus crisis.
One of those experts is Celine Gounder, an infectious diseases epidemiologist who has worked on Ebola, tuberculosis, and HIV in Africa and South America. She’s a clinical assistant professor of medicine and infectious diseases at New York University’s School of Medicine, as well as an active w riter and podcast host, including of Epidemic
In this podcast she talks to Joanne Silberner about the ways in which the taskforce is helping prepare for action immediately after the inau...
Source: The BMJ Podcast - January 19, 2021 Category: General Medicine Authors: BMJ talk medicine Source Type: podcasts
